SS Innovations International (SSII) Cash from Operations (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.14% |
| Dec 31, 2025 | 79.65% |
| Sep 30, 2025 | -116.31% |
| Jun 30, 2025 | 43.44% |
| Mar 31, 2025 | -87.12% |
| Dec 31, 2024 | -28.07% |
| Sep 30, 2024 | -149.06% |
| Jun 30, 2024 | 61.73% |
| Mar 31, 2024 | 39.19% |
| Dec 31, 2023 | 21.42% |
| Sep 30, 2023 | -93.35% |
| Jun 30, 2023 | -16.38% |
| Mar 31, 2023 | 12.47% |
| Dec 31, 2022 | -43.66% |
| Sep 30, 2022 | -76.25% |
| Jun 30, 2022 | -1,803.18% |
| Mar 31, 2022 | 48.61% |
| Dec 31, 2021 | 0.56% |
| Sep 30, 2021 | -112.49% |
| Jun 30, 2021 | 31.24% |
| Mar 31, 2021 | -1,232.48% |
| Dec 31, 2020 | 55.92% |
| Sep 30, 2020 | 35.53% |
| Jun 30, 2020 | 58.62% |
| Mar 31, 2020 | 58.03% |
| Dec 31, 2019 | 24.55% |
| Sep 30, 2019 | -324.77% |
| Jun 30, 2019 | 65.24% |
| Mar 31, 2019 | -13.99% |
| Dec 31, 2018 | 11.31% |
| Sep 30, 2018 | 12.85% |
| Jun 30, 2018 | -1.75% |
| Mar 31, 2018 | 19.65% |
| Dec 31, 2017 | -114.21% |
| Sep 30, 2017 | 41.63% |
| Jun 30, 2017 | -10.62% |
| Mar 31, 2017 | -83.29% |
| Dec 31, 2016 | 40.73% |